Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide.
Shweta UrvaTonya QuinlanJohn LandryJennifer MartinCorina LoghinPublished in: Clinical pharmacokinetics (2021)
ClinicalTrials.gov NCT03482024.
Keyphrases